List view / Grid view
Approval of the novel tool marks progress for both respiratory…
Approval of the novel tool marks progress for both respiratory disease patients in the UK and reducing the global environmental impact of inhaled medicines.
A new report has outlined that AstraZeneca has been granted…
A new report has outlined that AstraZeneca has been granted protection from product liability claims regarding its COVID-19 vaccine candidate.
The FDA has approved Bydureon BCise for adults with type-2 diabetes whose…
The FDA has approved Bydureon BCise for adults with type-2 diabetes whose blood sugar remains uncontrolled on one or more oral medicines...
